Supporting babies at high risk of cerebral palsy from the very beginning

Testing a family-centred early intervention program to improve outcomes for infants and support parents during the first critical months of life.

Supporting babies at high risk of cerebral palsy from the very beginning

July 1, 2026
Testing a family-centred early intervention program to improve outcomes for infants and support parents during the first critical months of life.
Read Transcript

The challenge

Cerebral palsy (CP) is the most common physical disability in childhood, affecting movement, posture and, for many children, speech, learning, feeding and other aspects of development. Every day in Australia, two babies are born with CP (Cerebral Palsy Alliance Research Institute, Sydney, 2023). While it is now possible to identify many infants at high risk within weeks of birth, access to evidence-based early intervention remains limited and inconsistent.

The first months of life are a critical period for brain development, when an infant's brain has its greatest capacity to adapt and learn. Supporting parents during this time is equally important, yet families of infants at high risk of CP often receive little structured support, despite mothers being more than 15 times more likely to experience depression than mothers of infants without CP.

A new approach to early intervention

Adjunct Associate Professor Cathy Morgan and Professor Nadia Badawi from Cerebral Palsy Alliance are evaluating the Very early Intensive Programme (VIP), a six-month intervention for babies identified as being at high risk of CP. Beginning when babies are between birth and four weeks’ corrected age, the program combines customised motor training and environmental enrichment with parent support and coaching.

The randomised controlled trial will involve 138 infants and compare the VIP with the standard parent education and monitoring that families currently receive. The study will assess whether the program improves infants' motor, cognitive and communication development, while also supporting parents' wellbeing, confidence and quality of life.

Early impact

The study is now underway, with recruitment across 10 neonatal intensive care units and special care nurseries in New South Wales. To date, 27 infants have been screened for eligibility, and 19 families have been enrolled in the trial. Although the study is still recruiting participants and analysis has yet to begin, many families have already shared positive feedback about their experience with the VIP intervention.

Parents have spoken about the value of the customised, family-centred approach and the confidence they have gained through personalised coaching and support during the first months of their baby's life. Several families have also reached out to the research team to express their appreciation for the program. 

Beyond the trial, a monthly peer support group, led by parents with lived experience of raising a child with CP, has been established to help families connect with others navigating similar experiences. Resources have also been developed to support health professionals in having early diagnostic conversations with families. Listen to the podcast below to learn more about why these early conversations matter.

What this could unlock

If successful, the VIP Study will provide important evidence to guide the delivery of early intervention for infants at high risk of CP. The research aims to inform future clinical practice and policy, helping ensure families receive evidence-based, family-centred support during the earliest stages of their child's development. Researchers also hope to expand the model for families living in regional and remote Australia, where access to specialist allied health services is often limited.

Funding support from Hearts & Minds. This content was last updated in July 2026. For further information, visit Cerebral Palsy Alliance.

The challenge

Cerebral palsy (CP) is the most common physical disability in childhood, affecting movement, posture and, for many children, speech, learning, feeding and other aspects of development. Every day in Australia, two babies are born with CP (Cerebral Palsy Alliance Research Institute, Sydney, 2023). While it is now possible to identify many infants at high risk within weeks of birth, access to evidence-based early intervention remains limited and inconsistent.

The first months of life are a critical period for brain development, when an infant's brain has its greatest capacity to adapt and learn. Supporting parents during this time is equally important, yet families of infants at high risk of CP often receive little structured support, despite mothers being more than 15 times more likely to experience depression than mothers of infants without CP.

A new approach to early intervention

Adjunct Associate Professor Cathy Morgan and Professor Nadia Badawi from Cerebral Palsy Alliance are evaluating the Very early Intensive Programme (VIP), a six-month intervention for babies identified as being at high risk of CP. Beginning when babies are between birth and four weeks’ corrected age, the program combines customised motor training and environmental enrichment with parent support and coaching.

The randomised controlled trial will involve 138 infants and compare the VIP with the standard parent education and monitoring that families currently receive. The study will assess whether the program improves infants' motor, cognitive and communication development, while also supporting parents' wellbeing, confidence and quality of life.

Early impact

The study is now underway, with recruitment across 10 neonatal intensive care units and special care nurseries in New South Wales. To date, 27 infants have been screened for eligibility, and 19 families have been enrolled in the trial. Although the study is still recruiting participants and analysis has yet to begin, many families have already shared positive feedback about their experience with the VIP intervention.

Parents have spoken about the value of the customised, family-centred approach and the confidence they have gained through personalised coaching and support during the first months of their baby's life. Several families have also reached out to the research team to express their appreciation for the program. 

Beyond the trial, a monthly peer support group, led by parents with lived experience of raising a child with CP, has been established to help families connect with others navigating similar experiences. Resources have also been developed to support health professionals in having early diagnostic conversations with families. Listen to the podcast below to learn more about why these early conversations matter.

What this could unlock

If successful, the VIP Study will provide important evidence to guide the delivery of early intervention for infants at high risk of CP. The research aims to inform future clinical practice and policy, helping ensure families receive evidence-based, family-centred support during the earliest stages of their child's development. Researchers also hope to expand the model for families living in regional and remote Australia, where access to specialist allied health services is often limited.

Funding support from Hearts & Minds. This content was last updated in July 2026. For further information, visit Cerebral Palsy Alliance.

Disclaimer: This material has been prepared by Hearts & Minds, published on July 1, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
July 1, 2026

Improving care for adults with motor neuron diseases

Building better care for adults living with Motor Neuron Disease and Spinal Muscular Atrophy.

Read More
July 1, 2026

Understanding fatigue in young people with Charcot-Marie-Tooth disease

Developing a tool to improve understanding, research and care.

Read More
Picture: Professor Gina Ravenscroft and her teamPicture: Professor Gina Ravenscroft and her teamPicture: Professor Gina Ravenscroft and her teamPicture: Professor Gina Ravenscroft and her team
July 1, 2026

Giving families living with rare diseases the answers they need

Supporting research to improve the diagnosis of rare genetic neuromuscular diseases and build the foundations for future treatments.

Read More
Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher
July 1, 2026

Understanding spinal cord injury recovery

The world's first molecular map of spinal cord injury across time and injury levels

Read More
Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium
July 1, 2026

Building the foundations for faster progress against brain cancer

Uniting researchers, clinicians and patients to accelerate research and improve patient care.

Read More
July 1, 2026

Accelerating CAR-T cell therapies for patients in need 

Bringing innovative cancer therapies closer to patients.

Read More
July 1, 2026

Making early cerebral palsy screening more accessible

Exploring new ways to identify babies at risk of cerebral palsy sooner and support better outcomes.

Read More
December 5, 2023

Prof Daniel MacArthur | 2023 Sohn Hearts & Minds Conference

At the 2023 Sohn Hearts & Minds Conference, we heard from Prof Daniel MacArthur, the Director of the Centre for Population Genomics.

Read More
December 5, 2023

Prof Michelle Simmons AO | Sohn Hearts & Minds Conference

At this year's Sohn Hearts & Minds Conference, we heard from Prof Michelle Simmons, the CEO and Founder of Silicon Quantum Computing.

Read More
December 5, 2023

Prof Misty Jenkins AO | 2023 Sohn Hearts & Minds Conference

At the 2023 Sohn Hearts & Minds Conference, we heard from Prof Misty Jenkins. Misty is a NHMRC fellow and laboratory head of the Immunology Division at the Walter and Eliza Hall Institute.

Read More
Daniel MacArthur speaking at the 2023 Sohn Hearts & Minds Conference in Sydney.Daniel MacArthur speaking at the 2023 Sohn Hearts & Minds Conference in Sydney.Daniel MacArthur speaking at the 2023 Sohn Hearts & Minds Conference in Sydney.Daniel MacArthur speaking at the 2023 Sohn Hearts & Minds Conference in Sydney.
November 15, 2023

Advancing Medicine Is In Daniel MacArthur’s DNA

When genomic scientist Daniel MacArthur had the opportunity to set up a new Centre for Population Genomics in Australia in 2019, he jumped at the chance to return home after 12 years living overseas.

Read More
November 10, 2023

Big thinkers in hunt for brain cancer cure

“Brain cancer is rare, but for people who do get it the prognosis is not good,” Assistant Professor Jenkins tells The Australian.

Read More
April 20, 2023

Artificial intelligence gives new hope for sufferers of severe heart problem

New AI software can improve the diagnosis of severe aortic stenosis by 72% and could potentially change the lives of about 50,000 Australians with the life-threatening condition.

Read More
February 14, 2023

Bringing Equity and Diversity to Genomic Medicine

Professor Daniel MacArthur, Director of the Centre for Population Genomics has big goals to bring equity and diversity into genomic medicine in Australia, something surprisingly inadequate presently.

Read More
September 6, 2022

VCCRI: 'Heart in a Box'

An Australian method of preserving donated hearts has boosted the number of successful transplants across the world, with new research demonstrating similar survival rates to traditional transplants.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.